Search for: "A AND L LABORATORIES INC" Results 441 - 460 of 523
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Oct 2014, 12:09 pm by Schachtman
Since 1663, the Royal Society has sported the motto:  “Nullius in verba,” on no one’s authority. [read post]
27 Jun 2024, 12:58 pm by jeffreynewmanadmin
” Distribution of Adderall and Other Stimulants Five additional defendants associated with digital technology company Done Global Inc. and its affiliated entity, Done Health P.C. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
9 Jul 2012, 1:11 pm
Pioneer HiBred Int'l, Inc., 534 U.S. 124, 135 (2001). [read post]
12 Jan 2010, 5:00 am by Beck, et al.
Abbot Laboratories, No. 08 Civ. 7480, 2009 WL 2231701 (S.D.N.Y. [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
27 Feb 2010, 3:35 pm by Drew Falkenstein
  Epidemiological investigation showed that these 238 sick people all ate Daniele Inc salami products contaminated by salmonella. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram)… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
20 Dec 2018, 9:22 am by Schachtman
  Selikoff received the Albert Lasker Clinical Medical Research Award for his work on the clinical trial of isoniazid to treat tuberculosis, along with Walsh McDermott and Carl Muschenheim, of the Hoffmann-La Roche Research Laboratories, and Edward H. [read post]
15 Jan 2008, 1:36 pm
U.S. 4th Circuit Court of Appeals, January 10, 2008 DIRECTV, Inc. v. [read post]
2 Jan 2022, 9:01 pm by News Desk
The drain in close proximity to this exposed rebar near Cooler (redacted) was found positive for L. monocytogenes (Sub Sample #101). [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jan 2011, 6:08 pm
Marcelline Burns and Herbert Moskowitz, doing business as the Southern California Research Institute, were awarded a contract by the NHTSA to conduct laboratory studies of various FSTs then in use around the country, with the goal of identifying the most effective battery of FSTs. [read post]
7 Apr 2010, 3:44 pm by admin
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
19 Sep 2014, 11:19 pm by Jon Gelman
Comprehensive vaccination strategies that include making vaccine available at no cost at the workplace along with active promotion of vaccination might be needed to increase vaccination coverage among HCP and minimize the risk for influenza to HCP and their patients.The opt-in Internet panel survey was conducted for CDC by Abt Associates, Inc. [read post]